Hypoxia Clinical Trial
Official title:
Effect of the Author's Training Program in Normobaric Hypoxia on Changes in Bone Turnover Markers and Carbohydrate and Lipid Metabolism in Premenopausal Women
The impact of a proprietary training program in normobaric hypoxia on changes in bone turnover markers as well as carbohydrate and lipid metabolism in premenopausal women falls within the realm of physical culture for an active and healthy society. Within this context, the implementation of a project is supported aiming to: 1. Monitor, support, and promote physical development, fitness, and physical activity in society, by assessing the effects of a proprietary training program in normobaric hypoxia on changes in bone turnover markers as well as carbohydrate and lipid metabolism in premenopausal women. 2. Develop and implement innovative methods, forms, and means of physical activation and training for individuals of various ages, by formulating general assumptions of an endurance-strength training concept under normobaric hypoxia conditions, concerning changes in bone turnover markers as well as carbohydrate and lipid metabolism in premenopausal women. 3. Prevent injuries in physical education and sports, by designing a useful training program for osteoporosis prevention as well as for managing carbohydrate and lipid metabolism disorders in premenopausal women.
Status | Recruiting |
Enrollment | 60 |
Est. completion date | December 2026 |
Est. primary completion date | December 2026 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 50 Years to 59 Years |
Eligibility | Inclusion Criteria: - No significant cardiovascular, respiratory system diseases and musculoskeletal system, - No contraindications to physical activity. ECG, baseline urinalysis, morphology are required. - T-score within normal limits (+1.0 to -1.0). - Informed consent of the patient to participate in the study. Exclusion Criteria: - Use of hormone replacement therapy (HRT). - Use of substances (cigarettes, alcohol). - Any training (including hypoxia training or exposure) performed in the 6 months prior to the beginning of the intervention - Any other factors determined by the study investigators as unsuitable for participation. |
Country | Name | City | State |
---|---|---|---|
Poland | University School of Physical Education in Cracow | Krakow | |
Poland | University School of Physical Education in Cracow | Kraków |
Lead Sponsor | Collaborator |
---|---|
University School of Physical Education, Krakow, Poland | Ministry of Education and Science,Poland |
Poland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Blood analysis- part 1 | Bone turnover markers: bone-specific alkaline phosphatase (ng/ml), osteocalcin (ng/ml), N-terminal telopeptide of type I collagen (ng/ml), osteoprotegerin (ng/ml), 25-hydroxyvitamin D3 metabolite (ng/ml). | Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts | |
Primary | Blood analysis- part 2 | Hormones of lipid metabolism: adiponectin (µg/mL) | Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts | |
Primary | Blood analysis- part 3 | Hormones of lipid metabolism: lipid profile (mg/dL) | Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts | |
Primary | Blood analysis- part 4 | Hormones of lipid metabolism: lipoprotein atherogenicity index (no unit) | Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts | |
Primary | Blood analysis- part 5 | Hormones of carbohydrate metabolism: glucose (mg/dL) | Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts | |
Primary | Blood analysis- part 6 | Hormones of carbohydrate metabolism: insulin (IU/mL), leptin (IU/mL), ghrelin (IU/mL) | Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts | |
Primary | Blood analysis- part 7 | Thyroid hormones: Thyroid Stimulating Hormone (IU/L) | Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts | |
Primary | Blood analysis- part 8 | Vitamins: Vitamin D (ng/mL) | Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts | |
Primary | Blood analysis- part 9 | Plasma volume changes (ml/kg) | Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts | |
Primary | Blood analysis- part 10 | Rheology: viscosity (Pa·s), viscoelasticity (Pa·s) | Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts | |
Primary | Blood analysis- part 11 | Rheology: shear rate (s-¹) | Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts | |
Primary | Blood analysis- part 12 | Rheology: shear stress (Pa), elastic modulus (Pa) | Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts | |
Primary | Blood analysis- part 13 | Blood biochemistry: erythrocytes (million/µL) | Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts | |
Primary | Blood analysis- part 14 | Blood biochemistry: leukocytes (thousand/µL), platelets (thousand/µL) | Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts | |
Primary | Blood analysis- part 15 | Blood biochemistry: hemoglobin (g/dL) | Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts | |
Primary | Blood analysis- part 16 | Blood biochemistry: hematocrit (%), red cell distribution width (%) | Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts | |
Primary | Blood analysis- part 17 | Blood biochemistry: mean corpuscular volume (femtoliter) | Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts | |
Primary | Blood analysis- part 18 | Blood biochemistry: mean corpuscular hemoglobin (picogram) | Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts | |
Primary | Blood analysis- part 19 | Blood biochemistry: mean corpuscular hemoglobin concentration (g/dL), albumin (g/dL) | Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts | |
Primary | Blood analysis- part 20 | Blood biochemistry: creatinine (mg/dL), bilirubin (mg/dL), blood urea nitrogen (mg/dL) | Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts | |
Primary | Blood analysis- part 21 | Blood biochemistry: erythrocyte sedimentation rate (mm/h) | Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts | |
Primary | Blood analysis- part 22 | Blood biochemistry: alanine aminotransferase (U/L), aspartate aminotransferase (U/L) | Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts | |
Primary | Blood analysis- part 23 | Blood biochemistry: ferritin (ng/mL) | Before (10 minutes) and after (3 minutes) the first and last training.The training will last 4 weeks and will consist of 12 workouts | |
Primary | Bone mass- part 1 | To identify quantitative indicators of bone mass, a densitometric study will be performed using dual energy X-ray absorptiometry (DXA). Selected quantitative indicators of bone mass will be measured: bone mineral density (g/cm^2). | 1 day before and 1 day after the training program. Training will last 4 weeks. | |
Primary | Bone mass- part 2 | To identify quantitative indicators of bone mass, a densitometric study will be performed using dual energy X-ray absorptiometry (DXA). Selected quantitative indicators of bone mass will be measured: T-score (no unit). | 1 day before and 1 day after the training program. Training will last 4 weeks. | |
Primary | Bone mass- part 3 | To identify quantitative indicators of bone mass, a densitometric study will be performed using dual energy X-ray absorptiometry (DXA). Selected quantitative indicators of bone mass will be measured: Z-score (no unit). | 1 day before and 1 day after the training program. Training will last 4 weeks. | |
Primary | Bone mass- part 4 | To identify quantitative indicators of bone mass, a densitometric study will be performed using dual energy X-ray absorptiometry (DXA). Selected quantitative indicators of bone mass will be measured: relative skeletal-muscular index (kg/m^2). | 1 day before and 1 day after the training program. Training will last 4 weeks. | |
Primary | Somatic indicators- part 1 | A densitometry study using dual energy X-ray absorptiometry (DXA) will be conducted to determine body composition: lean body mass (kg). | 1 day before and 1 day after the training program. Training will last 4 weeks. | |
Primary | Somatic indicators- part 2 | A densitometry study using dual energy X-ray absorptiometry (DXA) will be conducted to determine body composition: percentage of body fat (%). | 1 day before and 1 day after the training program. Training will last 4 weeks. | |
Primary | Somatic indicators- part 3 | A densitometry study using dual energy X-ray absorptiometry (DXA) will be conducted to determine body composition: fat mass (kg). | 1 day before and 1 day after the training program. Training will last 4 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04498598 -
Structural Modification In Supraglottic Airway Device
|
N/A | |
Completed |
NCT05532670 -
N600X Low Saturation Accuracy Validation
|
||
Enrolling by invitation |
NCT04106401 -
Intravascular Volumes in Hypoxia During Antarctic Confinement
|
N/A | |
Recruiting |
NCT05883137 -
High-flow Nasal Oxygenation for Apnoeic Oxygenation During Intubation of the Critically Ill
|
||
Not yet recruiting |
NCT05817448 -
Hypoxia-induced Autophagy in the Pathogenesis of MAP
|
||
Recruiting |
NCT02661152 -
DAHANCA 30: A Randomized Non-inferiority Trial of Hypoxia-profile Guided Hypoxic Modification of Radiotherapy of HNSCC.
|
Phase 3 | |
Terminated |
NCT02801162 -
Evaluation of Accuracy and Precision of a New Arterial Blood Gas Analysis System Blood in Comparison With the Reference Standard
|
N/A | |
Not yet recruiting |
NCT02201875 -
Intrinsic Periodic Pattern of Breathing
|
N/A | |
Completed |
NCT02943863 -
Regional Ventilation During High Flow Nasal Cannula and Conventional Nasal Cannula in Patients With Hypoxia
|
N/A | |
Completed |
NCT02105298 -
Effect of Volume and Type of Fluid on Postoperative Incidence of Respiratory Complications and Outcome (CRC-Study)
|
N/A | |
Completed |
NCT01922401 -
Inverse Ratio Ventilation on Bariatric Operation
|
N/A | |
Active, not recruiting |
NCT01681238 -
Goal-directed Therapy in High-risk Surgery
|
N/A | |
Completed |
NCT01463527 -
Using Capnography to Reduce Hypoxia During Pediatric Sedation
|
N/A | |
Completed |
NCT01507623 -
Value of Capnography During Nurse Administered Propofol Sedation (NAPS)
|
N/A | |
Withdrawn |
NCT00638040 -
The Gene Expression Studies of the Role of Tumor Microenvironments in Tumor Progression
|
N/A | |
Active, not recruiting |
NCT06097754 -
Intermittent Exogenous Ketosis (IEK) at High Altitude
|
N/A | |
Completed |
NCT04589923 -
The VISION-Acute Study
|
||
Completed |
NCT05044585 -
Evaluation of RDS MultiSense® in Desaturation Analysis in Healthy Volunteers
|
N/A | |
Completed |
NCT03659513 -
The Effect of ECMO on the Pharmacokinetics of the Drugs and Their Clinical Efficacy
|
||
Completed |
NCT03221387 -
Sleep and Daytime Use of Humidified Nasal High-flow Oxygen in COPD Outpatients
|
N/A |